Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer
2008

Impact of Tumor VEGF Expression on Chemotherapy and Antiangiogenic Therapy in Ovarian Cancer

Sample size: 10 publication 10 minutes Evidence: moderate

Author Information

Author(s): David O. Holtz, Robert T. Krafty, Alisha Mohamed-Hadley, Lin Zhang, Ioannis Alagkiozidis, Benjamin Leiby, Wensheng Guo, Phyllis A. Gimotty, George Coukos

Primary Institution: University of Pennsylvania

Hypothesis

Does tumor VEGF expression influence the efficacy of low-dose chemotherapy combined with antiangiogenic therapy?

Conclusion

Tumor VEGF expression significantly affects the interactions between low-dose chemotherapy and antiangiogenic therapy, with low VEGF tumors benefiting more from the combination.

Supporting Evidence

  • Low-dose paclitaxel showed additive effects with antiangiogenic therapy in tumors with low VEGF expression.
  • High VEGF expression in tumors led to antagonistic interactions with low-dose chemotherapy.
  • Statistical modeling revealed significant differences in tumor response based on VEGF levels.

Takeaway

This study shows that some tumors respond better to a mix of chemotherapy and anti-cancer drugs if they have low levels of a protein called VEGF.

Methodology

The study used ID8 and ID8-Vegf mouse models to analyze the effects of low-dose paclitaxel and SU5416 on tumor growth and microvascular density.

Potential Biases

Potential bias due to the use of a single mouse model and the specific conditions of the experiments.

Limitations

The study used a flank model rather than an orthotopic tumor model, which may limit the applicability of the findings to human ovarian cancer.

Participant Demographics

Female C57BL/6 mice aged six to eight weeks were used in the experiments.

Statistical Information

P-Value

0.0029

Confidence Interval

95% Bayesian confidence intervals

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1479-5876-6-2

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication